Corteva (NYSE:CTVA) Stock Price Target Lowered at KeyCorp

Corteva (NYSE:CTVA – Get Free Report) had its target price cut by analysts at KeyCorp from $17.00 to $14.00 in a report released on Monday, Benzinga reports. The firm currently has an “overweight” rating on the stock. KeyCorp‘s price target would indicate a potential upside of 48.70% from the company’s previous close.

A number of other brokerages have also commented on CTVA. Mizuho set a $16.00 price target on shares of Corteva in a research note on Thursday. BMO Capital Markets set a $15.00 price objective on shares of Corteva in a research note on Friday, October 2nd. Weiss Ratings cut shares of Corteva from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, August 3rd. New Street Research set a $17.00 target price on shares of Corteva in a research report on Monday, October 5th. Finally, Wall Street Zen downgraded shares of Corteva from a “hold” rating to a “sell” rating in a research report on Saturday. Fifteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $52.47.

View Our Latest Report on Corteva

Corteva Price Performance

Shares of CTVA opened at $9.41 on Monday. Corteva has a 12-month low of $9.01 and a 12-month high of $90.97. The business’s fifty day moving average is $37.22 and its 200 day moving average is $69.57. The company has a quick ratio of 1.08, a current ratio of 1.56 and a debt-to-equity ratio of 0.14. The stock has a market cap of $6.28 billion, a P/E ratio of 4.96, a P/E/G ratio of 1.25 and a beta of 0.58.

Hedge Funds Weigh In On Corteva

A number of hedge funds have recently bought and sold shares of CTVA. EFG International AG bought a new stake in shares of Corteva in the 2nd quarter worth $25,000. Compass Financial Management LLC purchased a new stake in shares of Corteva in the second quarter valued at about $25,000. Elevation Wealth Partners LLC lifted its position in shares of Corteva by 334.6% during the second quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock valued at $29,000 after purchasing an additional 261 shares in the last quarter. Clearstead Trust LLC bought a new position in shares of Corteva during the second quarter valued at about $31,000. Finally, N.E.W. Advisory Services LLC bought a new position in shares of Corteva during the second quarter valued at about $33,000. 81.54% of the stock is owned by hedge funds and other institutional investors.

About Corteva

(Get Free Report)

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.

Featured Articles

Analyst Recommendations for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.